Brief: Epigenomics Places Mandatory Convertible Bond Of EUR 5.5 Million
28/01/2021 07:06
Jan 28 (Reuters) - Epigenomics AG ECXn.DE :
* SAID ON WEDNESDAY SUCCESSFULLY PLACED MANDATORY
CONVERTIBLE BOND
IN THE FULL AMOUNT OF EUR 5.5 MILLION
* THE GROSS PROCEEDS FROM THE ISSUANCE OF THE MANDATORY
CONVERTIBLE BOND AMOUNT TO EUR 5.5 MILLION
Source text for Eikon: ID:nEQc44jw1a
Further company coverage: ECXn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns